Protein - DNA Interaction Assays Search Results


91
Proteintech rabbit anti cib1 antibody
Rabbit Anti Cib1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/CIB1+Antibody/pmc04248985-159-0-5
Average 91 stars, based on 1 article reviews
rabbit anti cib1 antibody - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
Proteintech anti ctip
Anti Ctip, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/RBBP8+Antibody/pmc11130726-154-12-14
Average 93 stars, based on 1 article reviews
anti ctip - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Boster Bio p46 monoclonal antibody
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
P46 Monoclonal Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/Anti-POLDIP3+Antibody/pm27234543-59-47-58
Average 90 stars, based on 1 article reviews
p46 monoclonal antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Boster Bio anti cib1
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Anti Cib1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/Anti-CIB1+Antibody+Picoband/ppr0124185-85-11-14
Average 90 stars, based on 1 article reviews
anti cib1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
TATAA Biocenter AB protein±dna interactions
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Protein±Dna Interactions, supplied by TATAA Biocenter AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/protein+dna+interactions/pm11424081-696-0-5
Average 90 stars, based on 1 article reviews
protein±dna interactions - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Makoto USA Inc biomolecular interaction between dna/rna and proteins
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Biomolecular Interaction Between Dna/Rna And Proteins, supplied by Makoto USA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/biomolecular+interaction+between+dna+rna+and+proteins/10__1021_slash_cen___v083n041__p062-3472-13-18
Average 90 stars, based on 1 article reviews
biomolecular interaction between dna/rna and proteins - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Chrom Tech hollow-fiber flow field-flow fractionation
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Hollow Fiber Flow Field Flow Fractionation, supplied by Chrom Tech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/probing+and+quantifying+dna+protein+interactions+with+asymmetrical+flow+field+flow+fractionation/pm25698553-208-17-23
Average 90 stars, based on 1 article reviews
hollow-fiber flow field-flow fractionation - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Chennai Corporation protein-dna interactions
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Protein Dna Interactions, supplied by Chennai Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/protein+dna+interactions/pmc06158747__gky732_supplemental_files-0-4-39
Average 90 stars, based on 1 article reviews
protein-dna interactions - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Biotechnology Information protein-dna interactions
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Protein Dna Interactions, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/protein+dna+interactions/10__1074_slash_mcp__m110__007492-92-16-31
Average 90 stars, based on 1 article reviews
protein-dna interactions - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
GeneGo Inc metadrug, curated database of human protein-protein and protein-dna interactions.
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Metadrug, Curated Database Of Human Protein Protein And Protein Dna Interactions., supplied by GeneGo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/metadrug++curated+database+of+human+protein+protein+and+protein+dna+interactions+/us08000949-776-24-22
Average 90 stars, based on 1 article reviews
metadrug, curated database of human protein-protein and protein-dna interactions. - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nonlinear Dynamics dynamics of dna bubble induced by site specific dna-protein interaction
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Dynamics Of Dna Bubble Induced By Site Specific Dna Protein Interaction, supplied by Nonlinear Dynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/dynamics+of+dna+bubble+induced+by+site+specific+dna+protein+interaction/10__17537_slash_2024__19__232-262-3-0
Average 90 stars, based on 1 article reviews
dynamics of dna bubble induced by site specific dna-protein interaction - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Databank Inc dna–protein interactions
Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary <t>(p46</t> <t>monoclonal</t> antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.
Dna–Protein Interactions, supplied by Databank Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Protein+-+DNA+Interaction+Assays/dna+protein+interactions/pmc03793239-61-31-26
Average 90 stars, based on 1 article reviews
dna–protein interactions - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary (p46 monoclonal antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.

Journal: Research in veterinary science

Article Title: In vitro protective efficacy of Lithium chloride against Mycoplasma hyopneumoniae infection.

doi: 10.1016/j.rvsc.2016.03.013

Figure Lengend Snippet: Fig. 1. Antibacterial activity of LiCl against M. hyopneumoniae (1 × 106 CCU/ml) infected PK-cells (1 × 105 cells/well). Cells infected with M. hyopneumoniae, XLW-1 for 10 h and treated with LiCl for 12 h. (A) DNA extracted and quantified by qRT–PCR (log10 copies of DNA/well). Data presented as Means ± SD (n = 3). ⁎p b 0.008 and ⁎⁎p b 0.001 vs. control. (B) M. hyopneumoniae treated with LiCl (direct inactivation) before inoculating into cells. (C) Cells treated with LiCl then infected with M. hyopneumoniae, XLW-1 (pre-infection). DNA was extracted and quantified by qRT–PCR as above. A direct effect on bacteria was observed but not in cells. Data presented as Means ± SD (n = 3) ⁎p b 0.05 and p b 0.54 vs. control. (D) Effect of LiCl treatment was evaluated by IFA. Cells washed, fixed and probed with primary (p46 monoclonal antibody) and secondary-FITC conjugated antibodies. FITC- fluorescence was measured at OD 535. ⁎⁎P b 0.001 vs. control.

Article Snippet: We further infected cells (1 × 105 cells/well) in 96-well plates with M. hyopneumoniae (1 × 106 CFU/ml) at 37 °C for 10 h. Cells washed and inoculated LiCl (10–40 mM) for 12 h. Expression level of M. hyopneumoniae surface antigen (p46) was evaluated by IFA using p46 monoclonal antibody (our laboratory) and FITC-conjugated goat antimouse secondary antibodies (Boster Biological Technology Company, China).

Techniques: Activity Assay, Infection, Quantitative RT-PCR, Control, Bacteria